AR008155A1 - USE OF A COMPOUND OF FORMULA I TO PREPARE A USEFUL MEDICINE TO TREAT AND PREVENT POST MENOPAUSIC CARDIOVASCULAR DISEASE IN WOMEN. - Google Patents
USE OF A COMPOUND OF FORMULA I TO PREPARE A USEFUL MEDICINE TO TREAT AND PREVENT POST MENOPAUSIC CARDIOVASCULAR DISEASE IN WOMEN.Info
- Publication number
- AR008155A1 AR008155A1 ARP970103968A ARP970103968A AR008155A1 AR 008155 A1 AR008155 A1 AR 008155A1 AR P970103968 A ARP970103968 A AR P970103968A AR P970103968 A ARP970103968 A AR P970103968A AR 008155 A1 AR008155 A1 AR 008155A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- women
- menopausic
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Uso de un compuesto de fórmula I para la manufactura de un medicamento útil para tratar enfermedades cardiovasculares en mujeres posmenopáusicas. Elidoxifeno es el compuesto preferido.Use of a compound of formula I for the manufacture of a medicament useful for treating cardiovascular diseases in postmenopausal women. Elidoxifene is the preferred compound.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2543996P | 1996-09-06 | 1996-09-06 | |
| US5066697P | 1997-06-24 | 1997-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008155A1 true AR008155A1 (en) | 1999-12-09 |
Family
ID=26699738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103968A AR008155A1 (en) | 1996-09-06 | 1997-08-29 | USE OF A COMPOUND OF FORMULA I TO PREPARE A USEFUL MEDICINE TO TREAT AND PREVENT POST MENOPAUSIC CARDIOVASCULAR DISEASE IN WOMEN. |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP0929216A4 (en) |
| JP (2) | JP2002515046A (en) |
| KR (2) | KR20000068472A (en) |
| CN (2) | CN1236313A (en) |
| AR (1) | AR008155A1 (en) |
| AU (2) | AU4247397A (en) |
| BR (2) | BR9711676A (en) |
| CA (2) | CA2264775A1 (en) |
| CO (2) | CO4920218A1 (en) |
| CZ (1) | CZ76699A3 (en) |
| IL (1) | IL128645A0 (en) |
| NO (2) | NO991096D0 (en) |
| PL (2) | PL332038A1 (en) |
| TR (2) | TR199900506T2 (en) |
| TW (1) | TW411273B (en) |
| WO (2) | WO1998009519A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998034608A1 (en) * | 1997-02-11 | 1998-08-13 | Novo Nordisk A/S | Methods for treatment or prophylaxis of menopausal symptoms |
| GB9827121D0 (en) * | 1998-12-09 | 1999-02-03 | Orion Corp | Agent for lowering endothelin levels |
| DE19905961A1 (en) * | 1999-02-12 | 2000-08-17 | Stefan Neubauer | Use of estrogens to treat cardiac insufficiency and left ventricular dysfunction following myocardial infarction |
| US6528681B2 (en) * | 2000-04-05 | 2003-03-04 | Bristol-Meyers Squibb Pharma Company | Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
| IL145876A0 (en) | 2000-10-17 | 2002-07-25 | Pfizer Prod Inc | Methods and kits for improving vascular health |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0260066B1 (en) * | 1986-09-11 | 1990-05-09 | National Research Development Corporation | Tamoxifen derivatives |
| KR100326962B1 (en) * | 1992-09-15 | 2002-12-02 | 메렐 파마슈티칼스 인크. | Tamoxifen-Non Metabolic Clomiphene Analog for Treatment of Tolerant Tumor |
| WO1996040098A2 (en) * | 1995-06-07 | 1996-12-19 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| US5681835A (en) * | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
| US5604248A (en) * | 1994-05-05 | 1997-02-18 | Eli Lilly And Company | Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| US5470883A (en) * | 1994-05-23 | 1995-11-28 | Stromberg; Brent V. | Method of treating peripheral vasoconstriction with tamoxifen citrate |
| HN1996000101A (en) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | COMBINED THERAPY FOR OSTEOPOROSIS |
| US6069175A (en) * | 1996-11-15 | 2000-05-30 | Pfizer Inc. | Estrogen agonist/antagonists treatment of atherosclerosis |
-
1997
- 1997-08-29 AR ARP970103968A patent/AR008155A1/en unknown
- 1997-09-03 CZ CZ99766A patent/CZ76699A3/en unknown
- 1997-09-03 BR BR9711676A patent/BR9711676A/en not_active Application Discontinuation
- 1997-09-03 IL IL12864597A patent/IL128645A0/en unknown
- 1997-09-03 KR KR1019997001860A patent/KR20000068472A/en not_active Application Discontinuation
- 1997-09-03 CN CN97199493A patent/CN1236313A/en active Pending
- 1997-09-03 AU AU42473/97A patent/AU4247397A/en not_active Abandoned
- 1997-09-03 TR TR1999/00506T patent/TR199900506T2/en unknown
- 1997-09-03 AU AU44097/97A patent/AU4409797A/en not_active Abandoned
- 1997-09-03 KR KR1019997001861A patent/KR20000068473A/en not_active Application Discontinuation
- 1997-09-03 JP JP51283798A patent/JP2002515046A/en active Pending
- 1997-09-03 PL PL97332038A patent/PL332038A1/en unknown
- 1997-09-03 CA CA002264775A patent/CA2264775A1/en not_active Abandoned
- 1997-09-03 CA CA002264943A patent/CA2264943A1/en not_active Abandoned
- 1997-09-03 JP JP51283898A patent/JP2002515047A/en active Pending
- 1997-09-03 PL PL97332278A patent/PL332278A1/en unknown
- 1997-09-03 CN CN97199492A patent/CN1236299A/en active Pending
- 1997-09-03 TR TR1999/00504T patent/TR199900504T2/en unknown
- 1997-09-03 EP EP97940773A patent/EP0929216A4/en not_active Withdrawn
- 1997-09-03 WO PCT/US1997/015474 patent/WO1998009519A1/en not_active Application Discontinuation
- 1997-09-03 EP EP97942388A patent/EP0927029A4/en not_active Withdrawn
- 1997-09-03 WO PCT/US1997/015475 patent/WO1998009619A1/en not_active Application Discontinuation
- 1997-09-03 BR BR9711681A patent/BR9711681A/en not_active Application Discontinuation
- 1997-09-04 CO CO97051287A patent/CO4920218A1/en unknown
- 1997-09-04 CO CO97051289A patent/CO5070658A1/en unknown
- 1997-12-11 TW TW086112930A patent/TW411273B/en active
-
1999
- 1999-03-05 NO NO991096A patent/NO991096D0/en not_active Application Discontinuation
- 1999-03-05 NO NO991097A patent/NO991097D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO991096L (en) | 1999-03-05 |
| PL332038A1 (en) | 1999-08-16 |
| KR20000068473A (en) | 2000-11-25 |
| AU4247397A (en) | 1998-03-26 |
| EP0927029A1 (en) | 1999-07-07 |
| CO5070658A1 (en) | 2001-08-28 |
| AU4409797A (en) | 1998-03-26 |
| BR9711681A (en) | 1999-08-24 |
| BR9711676A (en) | 1999-08-24 |
| PL332278A1 (en) | 1999-08-30 |
| KR20000068472A (en) | 2000-11-25 |
| EP0929216A4 (en) | 2001-04-04 |
| CZ76699A3 (en) | 1999-08-11 |
| NO991097L (en) | 1999-03-05 |
| TR199900506T2 (en) | 1999-07-21 |
| WO1998009519A1 (en) | 1998-03-12 |
| CA2264775A1 (en) | 1998-03-12 |
| NO991096D0 (en) | 1999-03-05 |
| CN1236299A (en) | 1999-11-24 |
| CN1236313A (en) | 1999-11-24 |
| JP2002515047A (en) | 2002-05-21 |
| JP2002515046A (en) | 2002-05-21 |
| IL128645A0 (en) | 2000-01-31 |
| WO1998009619A1 (en) | 1998-03-12 |
| EP0929216A1 (en) | 1999-07-21 |
| TR199900504T2 (en) | 1999-06-21 |
| CA2264943A1 (en) | 1998-03-12 |
| CO4920218A1 (en) | 2000-05-29 |
| EP0927029A4 (en) | 2001-06-13 |
| NO991097D0 (en) | 1999-03-05 |
| TW411273B (en) | 2000-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2190472T3 (en) | TRANSDERMIC PATCH FOR THE ADMINISTRATION OF 17-DEACETIL NORGESTIMATO, ONLY OR IN COMBINATION WITH A STROGEN. | |
| DE69010336T2 (en) | PHARMACEUTICAL COMPOSITION FOR SLimming. | |
| TR199801180T2 (en) | New compounds with analgesic effect. | |
| NO20101190L (en) | Use of buprenorphine in the manufacture of a medicament | |
| ES2162615T3 (en) | METHOD TO TREAT OR PREVENT TYPE 1 DIABETES THROUGH ORAL INSULIN ADMINISTRATION. | |
| DE69738615D1 (en) | USE OF GLP-1 OR ANALOGS FOR THE TREATMENT OF MYOCARDIAL INFARC | |
| BR0108977A (en) | Azacyclic compounds for use in the treatment of serotonin-related diseases | |
| FI970747A (en) | Combination product for use in immunological diseases | |
| MY132705A (en) | Novel compounds with analgesic effect | |
| YU49026B (en) | THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA | |
| EP0350036A3 (en) | Topical hematoporphyrin | |
| PT1173201E (en) | METHOD FOR THE TREATMENT OF FIBROSIS USING AN ALTAGONIST OF THE ALPHA 4 SUBSTANCE OF INTEGRINA | |
| DE68912195T2 (en) | Use of pyrrolicloncarboxylic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis. | |
| DE69424777T2 (en) | 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS | |
| DK0714304T3 (en) | Therapeutic system for the treatment of psoriasis | |
| AR008155A1 (en) | USE OF A COMPOUND OF FORMULA I TO PREPARE A USEFUL MEDICINE TO TREAT AND PREVENT POST MENOPAUSIC CARDIOVASCULAR DISEASE IN WOMEN. | |
| TR199801184T2 (en) | New compounds with analgesic action. | |
| EE9800315A (en) | A method for treating heart failure using endothelin antagonists | |
| AR003979A1 (en) | TRANSDERMIC ADMINISTRATION OF VOROZOL. | |
| AR004330A1 (en) | USE OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF XEROSTOMY | |
| DE69729201T2 (en) | SULFON FLUORIDE FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| DE68905076T2 (en) | Pharmaceutical composition for the treatment of skin wounds. | |
| BR9701455A (en) | Use of bradykinin antagonists for the preparation of drugs for the treatment of chronic fibrogenetic liver diseases and acute liver diseases | |
| AR015537A1 (en) | USE OF BRINZOLAMIDE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OR PREVENT RETINA EDEMA. | |
| TR199900013T2 (en) | New bracelets. |